| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |